+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vical Inc - logo

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

Infectious Vaccine Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Infectious Vaccine Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 300 Pages
  • Global
From
Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • May 2022
  • 365 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • May 2024
  • 182 Pages
  • Global
From
Melanoma Drugs Global Market Report 2024 - Product Thumbnail Image

Melanoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape - Product Thumbnail Image

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

  • Report
  • March 2023
  • 182 Pages
  • Global
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2024 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

  • Report
  • March 2024
  • 400 Pages
  • Global
From
Metastatic Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
  • Global
From
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030 - Product Thumbnail Image

Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030

  • Report
  • July 2019
  • 800 Pages
  • Global
From
CAR-T Therapies Market (2nd Edition), 2019-2030 - Product Thumbnail Image

CAR-T Therapies Market (2nd Edition), 2019-2030

  • Report
  • August 2019
  • 580 Pages
  • Global
From
Immunostimulatory Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Immunostimulatory Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 87 Pages
  • Global
From
Cytomegalovirus (HHV-5) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Cytomegalovirus (HHV-5) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 322 Pages
  • Global
From
Vical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Vical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
  • 13 Results (Page 1 of 1)
Loading Indicator